{
  "input": {
    "mode": "build_chain",
    "query": {
      "entity": "Severe hypertriglyceridaemia",
      "relation": "indication"
    },
    "hypotheses": [
      {
        "id": "H1",
        "candidate": {
          "id": "drug_fibrates",
          "name": "Fibrates"
        },
        "mechanism_outline": "",
        "priority": 1.0
      },
      {
        "id": "H2",
        "candidate": {
          "id": "drug_niacin",
          "name": "Niacin"
        },
        "mechanism_outline": "",
        "priority": 0.95
      },
      {
        "id": "H3",
        "candidate": {
          "id": "drug_omega_3_fatty_acids",
          "name": "Omega-3 fatty acids"
        },
        "mechanism_outline": "",
        "priority": 0.9
      },
      {
        "id": "H4",
        "candidate": {
          "id": "drug_statins",
          "name": "Statins"
        },
        "mechanism_outline": "",
        "priority": 0.85
      },
      {
        "id": "H5",
        "candidate": {
          "id": "drug_lomitapide",
          "name": "Lomitapide"
        },
        "mechanism_outline": "",
        "priority": 0.8
      },
      {
        "id": "H6",
        "candidate": {
          "id": "drug_mipomersen",
          "name": "Mipomersen"
        },
        "mechanism_outline": "",
        "priority": 0.75
      },
      {
        "id": "H7",
        "candidate": {
          "id": "drug_evolocumab",
          "name": "Evolocumab"
        },
        "mechanism_outline": "",
        "priority": 0.7
      },
      {
        "id": "H8",
        "candidate": {
          "id": "drug_alirocumab",
          "name": "Alirocumab"
        },
        "mechanism_outline": "",
        "priority": 0.6499999999999999
      },
      {
        "id": "H9",
        "candidate": {
          "id": "drug_aspirin",
          "name": "Aspirin"
        },
        "mechanism_outline": "",
        "priority": 0.6
      },
      {
        "id": "H10",
        "candidate": {
          "id": "drug_clofibrate",
          "name": "Clofibrate"
        },
        "mechanism_outline": "",
        "priority": 0.55
      },
      {
        "id": "H11",
        "candidate": {
          "id": "drug_bezafibrate",
          "name": "Bezafibrate"
        },
        "mechanism_outline": "",
        "priority": 0.5
      },
      {
        "id": "H12",
        "candidate": {
          "id": "drug_fenofibrate",
          "name": "Fenofibrate"
        },
        "mechanism_outline": "",
        "priority": 0.44999999999999996
      }
    ],
    "tegraph_snapshot": {
      "nodes": [],
      "edges": [],
      "round_index": 1
    },
    "constraints": {
      "require_disjoint_paths": 2,
      "max_new_nodes": 50,
      "max_new_edges": 64,
      "batched": true
    },
    "ablation_config": {
      "enable_debate": true,
      "enable_skeptic": true,
      "enable_pi_interrupts": true,
      "enable_textual_feedback": true,
      "enable_heuristic_transfer": true,
      "enable_seed_regen": true,
      "weights": {
        "path_disjointness": 1.0
      },
      "mode": "graph"
    }
  },
  "output": {
    "graph_updates": {
      "add_nodes": [
        {
          "id": "n_fibrates",
          "type": "Drug",
          "label": "Fibrates",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_niacin",
          "type": "Drug",
          "label": "Niacin",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_omega_3",
          "type": "Drug",
          "label": "Omega-3 fatty acids",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_statins",
          "type": "Drug",
          "label": "Statins",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_lomitapide",
          "type": "Drug",
          "label": "Lomitapide",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_mipomersen",
          "type": "Drug",
          "label": "Mipomersen",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_evolocumab",
          "type": "Drug",
          "label": "Evolocumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_alirocumab",
          "type": "Drug",
          "label": "Alirocumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_aspirin",
          "type": "Drug",
          "label": "Aspirin",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_clofibrate",
          "type": "Drug",
          "label": "Clofibrate",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_bezafibrate",
          "type": "Drug",
          "label": "Bezafibrate",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_fenofibrate",
          "type": "Drug",
          "label": "Fenofibrate",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_severe_hypertriglyceridaemia",
          "type": "Disease",
          "label": "Severe hypertriglyceridaemia",
          "attrs": {
            "agent": "Proponent"
          }
        }
      ],
      "add_edges": [
        {
          "source": "n_fibrates",
          "target": "n_severe_hypertriglyceridaemia",
          "relation": "supports",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "Fibrates已被证实用于降低甘油三酯"
        },
        {
          "source": "n_niacin",
          "target": "n_severe_hypertriglyceridaemia",
          "relation": "supports",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "Niacin在临床上用于治疗高甘油三酯"
        },
        {
          "source": "n_omega_3",
          "target": "n_severe_hypertriglyceridaemia",
          "relation": "supports",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "Omega-3脂肪酸在降低甘油三酯方面具有支持性证据"
        },
        {
          "source": "n_statins",
          "target": "n_severe_hypertriglyceridaemia",
          "relation": "supports",
          "weight": 0.65,
          "agent": "Proponent",
          "rationale": "Statins对脂质调节有重要作用"
        },
        {
          "source": "n_lomitapide",
          "target": "n_severe_hypertriglyceridaemia",
          "relation": "supports",
          "weight": 0.6,
          "agent": "Proponent",
          "rationale": "Lomitapide用于恶性高甘油三酯血症的治疗"
        },
        {
          "source": "n_mipomersen",
          "target": "n_severe_hypertriglyceridaemia",
          "relation": "supports",
          "weight": 0.55,
          "agent": "Proponent",
          "rationale": "Mipomersen针对特定类型高甘油三酯血症"
        },
        {
          "source": "n_evolocumab",
          "target": "n_severe_hypertriglyceridaemia",
          "relation": "supports",
          "weight": 0.5,
          "agent": "Proponent",
          "rationale": "Evolocumab为高甘油三酯背景下的治疗方案"
        },
        {
          "source": "n_alirocumab",
          "target": "n_severe_hypertriglyceridaemia",
          "relation": "supports",
          "weight": 0.5,
          "agent": "Proponent",
          "rationale": "Alirocumab有助于LDL和甘油三酯控制"
        },
        {
          "source": "n_aspirin",
          "target": "n_severe_hypertriglyceridaemia",
          "relation": "supports",
          "weight": 0.45,
          "agent": "Proponent",
          "rationale": "Aspirin可能与甘油三酯变化有关，需进一步研究"
        },
        {
          "source": "n_clofibrate",
          "target": "n_severe_hypertriglyceridaemia",
          "relation": "supports",
          "weight": 0.4,
          "agent": "Proponent",
          "rationale": "Clofibrate曾用于甘油三酯管理"
        },
        {
          "source": "n_bezafibrate",
          "target": "n_severe_hypertriglyceridaemia",
          "relation": "supports",
          "weight": 0.4,
          "agent": "Proponent",
          "rationale": "Bezafibrate用于减少甘油三酯的大量研究支持"
        },
        {
          "source": "n_fenofibrate",
          "target": "n_severe_hypertriglyceridaemia",
          "relation": "supports",
          "weight": 0.4,
          "agent": "Proponent",
          "rationale": "Fenofibrate用于治疗高甘油三酯血症"
        }
      ]
    },
    "subconclusions": [
      {
        "id": "C1",
        "text": "多种药物显示出对严重高甘油三酯血症的治疗潜力",
        "confidence": "high"
      }
    ],
    "assumptions": [
      "药物具备到达目标组织的能力（常识判断）"
    ],
    "uncertainties": [
      "具体机制及长期结果尚需更多临床数据支持"
    ],
    "next_focus_for_pi": [
      "选择输出最优药物及其验证路径"
    ]
  }
}